Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GW Pharmaceuticals plc
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationBrain cancer
Indication DetailsTreat glioma; Treat recurrent glioblastoma multiforme (GBM)
Regulatory Designation
PartnerOtsuka Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today